Hoth Therapeutics Inc. (HOTH)
NASDAQ: HOTH
· Real-Time Price · USD
0.89
-0.01 (-1.00%)
At close: May 01, 2025, 3:57 PM
0.87
-2.51%
After-hours: May 01, 2025, 07:48 PM EDT
-1.00% (1D)
| Bid | 0.84 |
| Market Cap | 11.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.19M |
| EPS (ttm) | -1.28 |
| PE Ratio (ttm) | -0.7 |
| Forward PE | -1.92 |
| Analyst | Buy |
| Ask | 0.9 |
| Volume | 75,128 |
| Avg. Volume (20D) | 677,739 |
| Open | 0.90 |
| Previous Close | 0.90 |
| Day's Range | 0.86 - 0.90 |
| 52-Week Range | 0.58 - 3.80 |
| Beta | 0.64 |
About HOTH
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 15, 2019
Employees 2
Stock Exchange NASDAQ
Ticker Symbol HOTH
Website https://www.hoththerapeutics.com
Analyst Forecast
According to 4 analyst ratings, the average rating for HOTH stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 404.09% from the latest price.
Stock Forecasts3 months ago
+178.18%
Hoth Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
+1.05%
Hoth Therapeutics shares are trading higher after the company announced its board has approved the purchase of up to $1 million in Bitcoin.
